Significant Treatment Attrition Rate Seen in Multiple Myeloma

TUESDAY, Nov. 22, 2022 -- There is a significant treatment attrition rate in newly diagnosed multiple myeloma (NDMM), according to a study published in the November issue of Leukemia & Lymphoma.
Victor H. Jimenez-Zepeda, M.D., from Alberta...